BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/6/2021 11:38:49 AM | Browse: 322 | Download: 644
Publication Name World Journal of Diabetes
Manuscript ID 62829
Country/Territory Greece
Received
2021-01-19 12:13
Peer-Review Started
2021-01-19 12:15
To Make the First Decision
Return for Revision
2021-02-12 04:50
Revised
2021-02-26 14:23
Second Decision
2021-04-06 08:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-20 20:46
Articles in Press
2021-04-20 20:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-04-25 01:49
Typeset the Manuscript
2021-04-30 03:24
Publish the Manuscript Online
2021-05-06 11:18
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title COVID-19 and hyperglycemia/diabetes
Manuscript Source Invited Manuscript
All Author List Konstantinos Michalakis and Ioannis Ilias
Funding Agency and Grant Number
Corresponding Author Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou Hospital, 2 Elena Venizelou Sq, Athens GR-11521, Greece. iiliasmd@yahoo.com
Key Words COVID-19; Humans; SARS-CoV-2; Risk factors; Glucose; Inflammation; Diabetes
Core Tip The severe acute respiratory syndrome coronavirus 2 pathogen has led to the coronavirus disease 2019 (COVID-19) pandemic. This virus exerts multi-organ actions, after an initial respiratory infection. In early studies regarding COVID-19, type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response. Hyperglycemia in COVID-19, irrespective of insulin resistance or history of diabetes, is a portent of worse prognosis. Further studies will help to elucidate the link between glycemia and COVID-19.
Publish Date 2021-05-06 11:18
Citation Michalakis K, Ilias I. COVID-19 and hyperglycemia/diabetes. World J Diabetes 2021; 12(5): 642-650
URL https://www.wjgnet.com/1948-9358/full/v12/i5/642.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i5.642
Full Article (PDF) WJD-12-642.pdf
Full Article (Word) WJD-12-642.docx
Manuscript File 62829-Review-FilipodiaCL.docx
Answering Reviewers 62829-Answering reviewers.pdf
Audio Core Tip 62829-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 62829-Conflict-of-interest statement.pdf
Copyright License Agreement 62829-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 62829-Language certificate.pdf
Peer-review Report 62829-Peer-review(s).pdf
Scientific Misconduct Check 62829-Bing-Wang JL-1.jpg
Scientific Misconduct Check 62829-Scientific misconduct check.pdf
Scientific Editor Work List 62829-Scientific editor work list.pdf